Trailing Twelve Months Revenue Growth: Chimerix Inc (CMRX)

Public company logo of chimerix.com (CMRX)

The year-over-year sales trend over the last 12 months demonstrates the effectiveness of applying AI and robotics in drug formula discovery for Chimerix, Inc. (CMRX). The value -96.60 captures this metric, highlighting moderate financial stability driven by government contracts. Michael Sherman's strategy to develop high-margin oncology assets and the availability of liquidity strengthen investor confidence in management.

Chimerix, Inc. (CMRX): Revenue Growth YoY (Last 12 Months) from 02/11/2024 to 02/20/2024

Chimerix, Inc. - analytical breakdowns and key metrics (CMRX)

- stock price and consensus target price:
- company stock exchange capitalization indicators:
Summary company analytics:Chimerix, Inc
Brand item of Chimerix Inc

Chimerix, Inc. (CMRX) relies on the intellectual capital of oncology and biosafety experts, whose long-term R&D developments determine the business's market resilience. By comparing total revenue over the last 12 months with the same period last year, the TTM annual revenue trend offsets quarterly volatility, allowing investors to detect a slowdown in growth rates in a timely manner, even at the peak of market optimism.

Who Chimerix, Inc. competes with

Incyte Pharma - Sales Growth YoY (Last Twelve Months)|HUTCHMED Corp - Sales Growth YoY (TTM)|Trailing Twelve Months Revenue Growth Nuvation Bio Inc.|DAWN: Sales Growth YoY (TTM)|Revenue Growth Rate YoY (Last Twelve Months) Monopar Pharma MNPR|Revenue Growth YoY (Last 12 Months) INBX|Trailing Twelve Months Revenue Growth I-Mab Biopharma IMAB|Revenue Growth YoY (Last 12 Months) FENC (Fennec Pharmaceuticals)|HRTX (Heron Therapeutics Inc) - Revenue Dynamics YoY (Last Twelve Months)|Nuvectis Pharma, Inc. - Revenue Growth YoY (Last 12 Months)|Revenue Change YoY (Last 12 Months) CHRS (Coherus BioSciences)|Corbus Pharma - Sales Growth YoY (TTM)|Revenue Dynamics YoY (Last Twelve Months) CRDF (cardiffoncology.com)|BYSI: Sales Growth YoY (TTM)|Trailing Twelve Months Revenue Growth BioAtla Corp (BCAB)|Sales Growth YoY (Last Twelve Months) Lixte Biotechnology Holdings, Inc.|CTXR: Revenue Dynamics YoY (Last Twelve Months)|Sales Growth YoY (TTM) CLRB|Sales Growth YoY (TTM) BioLineRx Corporation (BLRX)|Sales Growth YoY (Last Twelve Months) Can-Fite BioPharma, Ltd. CANF|APRE (aprea.com) - Trailing Twelve Months Sales Growth|KZIA: Revenue Growth YoY (Last 12 Months)|Trailing Twelve Months Revenue Growth Silexion Therapeutics|NuCana plc (NCNA) - Sales Growth YoY (Last Twelve Months)|Revenue Growth YoY (Last 12 Months) Cyclacel Pharmaceuticals|GTHX (g1therapeutics.com) - Sales Growth YoY (TTM)|KRON: Revenue Dynamics YoY (Last Twelve Months)|Sales Growth YoY (Last Twelve Months) Kintara (KTRA)|Revenue Growth YoY (Last 12 Months) Oncternal ONCT|Portage Biotech - Revenue Growth YoY (Last 12 Months)